A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
NCT ID: NCT00556114
Last Updated: 2022-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2007-01-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retinal Oximtery Following Treatment for Diabetic Maculopathy
NCT01549132
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
NCT04505618
oCular Examination at Cell RESolution With Optical TransmissionTomography
NCT06976034
Optical Coherence Tomography Angiography Examinations in Chronic Retinal Artery Occlusion
NCT03357146
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
NCT01717937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Optical Coherence Tomography a non-contact, non-invasive means of documenting both tissue structure and blood flow changes in ocular disease and can provide high resolution cross-sectional images of tissue structure, direct visualization of blood flow in blood vessels of the eye.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Optical Coherence Tomography
Optical Coherence Tomography
Optical Coherence Tomography
Optical Coherence Tomography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical Coherence Tomography
Optical Coherence Tomography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Baruch D. Kuppermann, M.D., Ph.D.,Professor Department of Ophthalmology and Biomedical Engineering
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Baruch D Kuppermann,, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Ophthamology, University of California,Irvine
Zhongping Chen, Ph,D
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute University of California Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beckman Laser Institute, University of California,Irvine
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20043555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.